Successful eradication of genotype 4 HCV with telaprevir-based triple antiviral therapy

被引：0
|
作者：
Deneke, M. G. [1 ]
Dranoff, J. A. [1 ,2 ]
Duarte-Rojo, A. [1 ]
机构：
[1] Univ Arkansas Ciencias Med, Div Gastroenterol & Hepatol, 4301 W Markham 567, Little Rock, AR 72205 USA
[2] Arkansas Cent, Serv Invest, Serv Salud Vet Affairs, Little Rock, AR USA
来源：
REVISTA DE GASTROENTEROLOGIA DE MEXICO | 2014年 / 79卷 / 01期
关键词：
D O I：
10.1016/j.rgmx.2013.09.003
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：64 / 66
页数：4
相关论文
共 50 条
  • [1] Viral Hepatitis ( plus Antiviral Therapy) Efficacy of telaprevir-based triple therapy for genotype 1 hepatitis patients in Japan
    Sasaki, Masato
    Yoshida, Kenichi
    Inamura, Kazuki
    Obata, Masahiro
    Yoshinari, Motonari
    Idegami, Junko
    Tanaka, Hideki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 423 - 423
  • [2] Legionella pneumophila pneumonia during telaprevir-based triple therapy for HCV chronic hepatitis
    T. Tieghi
    R. Marocco
    V. Belvisi
    C. Del Borgo
    S. Savinelli
    M. Lichtner
    C. M. Mastroianni
    Infection, 2014, 42 : 225 - 226
  • [3] Legionella pneumophila pneumonia during telaprevir-based triple therapy for HCV chronic hepatitis
    Tieghi, T.
    Marocco, R.
    Belvisi, V.
    Del Borgo, C.
    Savinelli, S.
    Lichtner, M.
    Mastroianni, C. M.
    INFECTION, 2014, 42 (01) : 225 - 226
  • [4] HCV reinfection after liver transplantation - management and first experiences with telaprevir-based triple therapy
    Herzer, K.
    Papadopoulos-Koehn, A.
    Timm, J.
    Paul, A.
    Jochum, C.
    Gerken, G.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (36) : 1759 - 1764
  • [5] Telaprevir Based Antiviral Triple Therapy for HCV Recurrence in Genotype-1 Infected Liver Graft Recipients.
    Klein, Fritz
    Neuhaus, Ruth
    Hofmann, Joerg
    Guel, Safak
    Puhl, Gero
    Neuhaus, Peter
    Bahra, Marcus
    LIVER TRANSPLANTATION, 2013, 19 : S146 - S146
  • [6] Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?
    Shiffman, Mitchell L.
    Esteban, Rafael
    LIVER INTERNATIONAL, 2012, 32 : 54 - 60
  • [7] Patterns of viral load decline with telaprevir-based therapy in patients with genotype 1 chronic HCV infection
    Picchio, Gaston
    De Meyer, Sandra
    Dierynck, Inge
    Ghys, Anne
    Gritz, Linda
    Kieffer, Tara L.
    Bartels, Douglas J.
    Witek, Jim
    Bengtsson, Leif
    Luo, Donghan
    Kauffman, Robert S.
    Adda, Nathalie
    Sarrazin, Christoph
    JOURNAL OF CLINICAL VIROLOGY, 2014, 59 (03) : 148 - 155
  • [8] Safety and Efficacy of Telaprevir-Based Triple Therapy to Treat HCV Recurrence Post-Liver Transplantation
    Singh, Tavankit
    Singh, Gurshawn
    Fung, John J.
    Zein, Nizar N.
    Eghtesad, Bijan
    Alkhouri, Naim
    GASTROENTEROLOGY, 2014, 146 (05) : S980 - S980
  • [9] Sustained Virological Response Results of Telaprevir-based Triple Antiviral Treatment for Recurrent HCV Genotype 1 after Liver Transplantation: A Single Center Uniform Protocol
    Pungpapong, Surakit
    Murphy, Jennifer L.
    Henry, Tanisha M.
    Ryland, Kristen
    Yataco, Maria L.
    Satyanarayana, Raj
    Rosser, Barry
    Keaveny, Andrew
    HEPATOLOGY, 2013, 58 : 1046A - 1046A
  • [10] HCV KINETICS AND QUASISPECIES EVOLUTION WITHIN THE FIRST HOURS OF TELAPREVIR-BASED TRIPLE THERAPY IN PREVIOUSLY TREATED HCV-PATIENTS
    Cento, V.
    De Luca, F.
    Valenti, F.
    Tontodonati, M.
    Di Maio, V. C.
    Bellocchi, M. C.
    Armenia, D.
    Carioti, L.
    Trave, F.
    Cacciatore, P.
    Madeddu, G.
    Bertoli, A.
    Angelico, M.
    Babudieri, S.
    Parruti, G.
    Ceccherini-Silberstein, F.
    Perno, C. F.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S6 - S6
12345